Third-Party Contract and Early-Payment Discount in a Tripoli Pharmacy
Your independent pharmacy in Tripoli has average monthly sales of LBP 900 million at list price, a gross margin of 22%, and fixed costs of LBP 170 million per month. A third-party payer offers a one-year network contract: an 18% discount on list prices, payment 75 days after month-end, and projected incremental sales of LBP 270 million per month. Your bank overdraft costs 12% per year, and the payer has a reputation for late payment. Separately, your main wholesaler offers a 2% discount if you pay within 10 days instead of the standard 60 days. You have LBP 150 million of available cash. Receivables are LBP 300 million, of which LBP 80 million are overdue. The pharmacy employs six staff and runs one delivery vehicle. Chronic-disease medicines account for 40% of sales, and patients often cannot pay cash upfront.
1. Calculate the pharmacy's current monthly operating profit and evaluate the proposed network contract. Show your arithmetic and state whether you would sign as offered.
Read the worked answer
Current position
- Sales: LBP 900 million
- Gross margin: 22%, so gross profit = 0.22 × 900 = LBP 198 million
- Cost of goods sold = 900 − 198 = LBP 702 million (78% of sales)
- Fixed costs = LBP 170 million
- Operating profit = 198 − 170 = LBP 28 million per month
The pharmacy is profitable but thin: a 3.1% operating margin.
Contract arithmetic, assuming all contract sales are genuinely incremental
- Incremental list-price sales: LBP 270 million
- After 18% discount: 270 × 0.82 = LBP 221.4 million revenue
- Cost of goods at 78%: 270 × 0.78 = LBP 210.6 million
- Gross profit: 221.4 − 210.6 = LBP 10.8 million per month
- Financing cost of 75-day receivables at 12%: 221.4 × 0.12 × 75/365 = LBP 5.46 million
- Net contribution before bad debt and administration: about LBP 5.3 million per month
That is a 4% gross margin on the contract sales. One unpaid claim or one late payment wipes it out. After three months, roughly LBP 664 million would be tied up in receivables, which the pharmacy cannot finance from a LBP 150 million cash position.
The critical flaw: cannibalization
If the payer covers patients who already pay cash, the 18% discount is given on sales the pharmacy already has. If even LBP 270 million of current sales moved to the network, the lost revenue would be 270 × 0.18 = LBP 48.6 million per month-far more than the LBP 10.8 million gross profit from incremental sales. The contract would destroy the pharmacy's profit.
Decision
I would not sign as offered. I would counter with:
- A smaller discount, around 8–10%.
- Payment within 30–45 days.
- A clause limiting the discount to genuinely new patients or new products.
- A cap on monthly volume and a clear claims-dispute process.
Alternatively, I would decline and focus on cash-paying patients and higher-margin services.
2. Calculate the annualized cost of forgoing the wholesaler's 2% early-payment discount. Should the pharmacy use its LBP 150 million to take the discount? Explain the reasoning and the risks.
Read the worked answer
Annualized cost of forgoing the discount
The terms are 2% discount if paid within 10 days, otherwise net 60 days. The pharmacy gives up 2% to keep the money for an extra 50 days.
Using the standard formula:
Cost of forgoing = (discount ÷ (1 − discount)) × (365 ÷ extra days)
= (0.02 ÷ 0.98) × (365 ÷ 50)
= 0.02041 × 7.3
= about 14.9% per year
That is higher than the 12% overdraft cost. On purely financial grounds, borrowing or using available cash to take the discount is better than forgoing it, provided the pharmacy still has enough liquidity for payroll and essential purchases.
Applying it to LBP 150 million
- Discount saved: 150 × 0.02 = LBP 3 million
- Financing cost of paying 50 days early: 150 × 0.12 × 50/365 = LBP 2.47 million
- Net benefit: about LBP 0.53 million per cycle
The benefit is real but modest. If the full monthly purchase bill is LBP 702 million, LBP 150 million is only part of it; the pharmacy cannot take the discount on the whole invoice.
Risks and caveats
- Liquidity risk. Using all available cash may leave nothing for salaries, rent, or emergency stock.
- Overdue receivables. The LBP 80 million overdue is a better first target: collecting it improves cash without a financing cost.
- Supplier reliability. A discount is worthless if early payment leads to stock shortages or if the wholesaler later changes terms.
Recommendation
Take the discount selectively on fast-moving, high-value lines where the 2% saving exceeds the financing cost, but keep a cash buffer. Do not drain the account to the last lira. In parallel, collect overdue receivables and negotiate better terms.
3. Recommend two operational actions to improve cash flow without cutting essential chronic-disease stock. Explain how each action affects liquidity and patient care.
Read the worked answer
Action 1: Aggressively collect overdue receivables and tighten credit
The LBP 80 million overdue is cash already earned. I would:
- Assign one staff member to call the largest overdue accounts within 48 hours.
- Send written statements and offer a short payment plan where needed.
- Set a credit limit per patient or account and require a deposit for new credit customers.
- Stop extending credit to repeat defaulters, while preserving a confidential process for patients who genuinely cannot pay.
Liquidity effect: Collecting even half of the overdue amount releases LBP 40 million-more than the net benefit of the wholesaler discount on LBP 150 million. It reduces the need for overdraft financing.
Patient-care effect: A clear, fair credit policy avoids the informal accumulation of debt that often leads pharmacies to refuse service abruptly. Chronic-disease patients can be offered a payment plan rather than being turned away.
Action 2: Reduce slow-moving stock and negotiate consignment or narrow-pack purchasing
I would review the inventory by monthly sales and identify items with fewer than one turn per quarter. For those items:
- Return or exchange short-dated stock where the wholesaler allows it.
- Reduce order quantities and order more frequently.
- Negotiate consignment for expensive, slow-moving items so the pharmacy pays only when the item is dispensed.
Liquidity effect: Reducing excess inventory converts dead stock into cash and lowers holding costs, insurance, and expiry write-offs. It also reduces the amount exposed to currency and price changes.
Patient-care effect: The saved cash is redirected to the 40% of sales that are chronic-disease medicines. I would protect a core list of essential medicines-cardiac, diabetes, asthma, epilepsy, and thyroid products-and set minimum stock levels for them. The goal is not to cut stock indiscriminately but to cut the right stock.
What I would not do
I would not reduce essential chronic-disease stock or skimp on refrigeration, because a stock-out or a spoiled insulin batch harms patients and damages the pharmacy's reputation. Cash-flow recovery should come from receivables and excess inventory first.